Reflection and ReactionA silver lining on the horizon for glioblastoma
References (10)
- et al.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Lancet Oncol
(2009) - et al.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
N Engl J Med
(2005) - et al.
MGMT gene silencing and benefit from temozolomide in glioblastoma
N Engl J Med
(2005) - et al.
Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma
Cancer J
(2008) Radiation therapy and temozolomide in treating patients with newly diagnosed glioblastoma or gliosarcoma
There are more references available in the full text version of this article.
Cited by (15)
Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: In vitro and in vivo studies
2015, Colloids and Surfaces B: BiointerfacesCitation Excerpt :Gliomas are the most common intracranial tumors and account for more than 50% of all primary brain tumors, with glioblastoma multiforme (GBM) being the most prevalent and aggressive [1,2].
Glioblastoma Multiforme: Overview of Current Treatment and Future Perspectives
2012, Hematology/Oncology Clinics of North AmericaCitation Excerpt :In addition to the development of broad-based drug therapy, recognition of individualized variations in tumor histopathology or genetics may provide invaluable insight into the most effective treatment regimen for specific patients.136,150
A retrospective comparison of intensity-modulated arc therapy and 3-dimensional conformal approaches in the planning of grade 3 gliomas
2018, Journal of Radiotherapy in PracticeExpert opinion on translational research for advanced glioblastoma treatment
2023, Cancer Biology and MedicineLncRNA SNHG6 promotes LMO3 expression by sponging miR-543 in glioma
2020, Molecular and Cellular Biochemistry
Copyright © 2009 Elsevier Ltd. All rights reserved.